Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Dr. Lal Pathlabs Ltd.
Change Company   
BSE Code 539524
ISIN Demat INE600L01024
Book Value 279.43
NSE Code LALPATHLAB
Dividend Yield % 0.76
Market Cap 264072.97
P/E 49.09
EPS 64.21
Face Value 10  
01-Nov-2025 Dr. Lal PathLabs informs about press release
01-Nov-2025 Dr. Lal PathLabs informs about receipt of an asse...
24-Sep-2025 Dr. Lal Pathlabs gets nod to acquire property in ...
24-Sep-2025 Dr. Lal PathLabs informs about acquisition
20-Aug-2025 Dr. Lal Pathlabs pioneers AI integration in cance...
20-Aug-2025 Dr. Lal PathLabs informs about press release
20-Aug-2025 Dr. Lal Pathlabs surges on pioneering AI integrat...
01-Aug-2025 Dr. Lal PathLabs informs about press release
31-Jul-2025 Dr. Lal PathLabs informs about investor presentat...
31-Jul-2025 Dr. Lal PathLabs informs about press release
31-Jul-2025 Dr. Lal PathLabs informs about record date
24-Jul-2025 Dr. Lal PathLabs informs about analyst meet
25-Jun-2025 Dr. Lal PathLabs expands genomics capabilities wi...
25-Jun-2025 Dr. Lal PathLabs informs about press release
25-Jun-2025 Dr. Lal PathLabs surges on expanding genomics cap...
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.